Factors Associated with Renal Dysfunction, Including Highly Active Antiretroviral Therapy in Korean HIV-Infected Patients |
Yeo, Jee-Young
(Department of Pharmacy, National Medical Center)
Shin, Hyoung-Shik (Department of Internal Medicine, National Medical Center) Chin, Bum-Sik (Department of Internal Medicine, National Medical Center) Lee, Yu-Jeung (Graduate School of Clinical Pharmacy, Sookmyung Women's University) |
1 | Wyatt CM, Winston JA, Malvestutto CD, et al., Chronic kidney disease in HIV infection: an urban epidemic. AIDS. 2007; 21: 2101-3. DOI ScienceOn |
2 | Schwartz EJ, Szczech LA, Ross MJ, et al., Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol. 2005; 16: 2412-20. DOI ScienceOn |
3 | Roling J, Schmid H, Fischereder M, et al., HIV-associated renal diseases and highly active antiretroviral therapyinduced nephropathy. Clin Infect Dis. 2006; 42: 1488-95. DOI ScienceOn |
4 | Cheung CY, Wong KM, Lee MP, et al., Prevalence of chronic kidney disease in Chinese HIV-infected patients. Nephrol Dial Transplant. 2007; 22: 3186-90. DOI ScienceOn |
5 | Bourgoignie JJ, Ortiz-Interian C, Green DF, et al., Race, a cofactor in HIV-1-associated nephropathy. Transplant Proc. 1989; 21: 3899-901. |
6 | Szczech LA. Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management. Clin Infect Dis. 2001; 33: 115-9. DOI ScienceOn |
7 | Winston JA, Klotman ME, Klotman PE. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int. 1999; 55: 1036-40. DOI ScienceOn |
8 | Campbell LJ, Ibrahim F, Fisher M, et al., Spectrum of chronic kidney disease in HIV-infected patients. HIV Med. 2009; 10: 329-36. DOI ScienceOn |
9 | Overton ET, Nurutdinova D, Freeman J, et al., Factors associated with renal dysfunction within an urban HIVinfected cohort in the era of highly active antiretroviral therapy. HIV Med. 2009; 10: 343-50. DOI ScienceOn |
10 | Gupta SK, Eustace JA, Winston JA, et al., Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005; 40: 1559-85. DOI ScienceOn |
11 | K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39: S1-266. DOI ScienceOn |
12 | Winston JA. Assessing kidney function in HIV infection. AIDS Read. 2007; 17: 257-61, |
13 | New DHHS guidelines for antiretroviral therapy. AIDS Alert. 2010; 25: 21-4. |
14 | Reid A, Stohr W, Walker AS, et al., Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis. 2008; 46: 1271-81. DOI ScienceOn |
15 | Szczech LA, Gange SJ, van der Horst C, et al., Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 2002; 61: 195-202. DOI ScienceOn |
16 | Gardner LI, Holmberg SD, Williamson JM, et al., Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr. 2003; 32: 203-9. DOI ScienceOn |
17 | Msango L, Downs JA, Kalluvya SE, et al., Renal dysfunction among HIV-infected patients starting antiretroviral therapy. AIDS. 2011; 25: 1421-5. DOI ScienceOn |
18 | Szczech LA, Edwards LJ, Sanders LL, et al., Protease inhibitors are associated with a slowed progression of HIVrelated renal diseases. Clin Nephrol. 2002; 57: 336-41. DOI |
19 | Pavie J, Scemla A, Bouldouyre MA, et al., Severe acute renal failure in an HIV-infected patient after only 2 weeks of tenofovir-based antiretroviral therapy. AIDS Patient Care STDS. 2011; 25: 457-60. DOI |
20 | Rodriguez-Novoa S, Alvarez E, Labarga P, et al., Renal toxicity associated with tenofovir use. Expert Opin Drug Saf. 2010; 9: 545-59. DOI ScienceOn |
21 | Hall AM, Edwards SG, Lapsley M, et al., Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis. Am J Kidney Dis. 2009; 54: 1034-42. DOI ScienceOn |
22 | Vigano A, Bedogni G, Manfredini V, et al., Long-term renal safety of tenofovir disoproxil fumarate in vertically HIV-infected children, adolescents and young adults: a 60-month follow-up study. Clin Drug Investig. 2011; 31: 407-15. DOI ScienceOn |
23 | Ibrahim F, Naftalin C, Cheserem E, et al., Immunodeficiency and renal impairment are risk factors for HIVassociated acute renal failure. AIDS. 2010; 24: 2239-44. DOI ScienceOn |
24 | Dauchy FA, Lawson-Ayayi S, de La Faille R, et al., Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy. Kidney Int. 2011; 80: 302-9. DOI ScienceOn |